Oscient Pharmaceuticals Announces Management Change
22-Dec-2008
- USA
Mr. Colangelo will provide business development consulting services to Oscient through January 31, 2009, with the potential for extension. He will be entitled to consulting fees, as well as an incentive for completion of certain business development objectives.
Anthony Watkins, Vice President of Corporate Development, will direct all business development efforts and will now report to Mr. Rauscher.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.